Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Etablissement Français du Sang |
---|---|
Information provided by: | Etablissement Français du Sang |
ClinicalTrials.gov Identifier: | NCT00235183 |
The aim of the study is to compare the clinical efficacy of three types of plasma secured on the viral level either by quarantine or by chemical treatment in patients undergoing liver transplantation.
Condition | Intervention | Phase |
---|---|---|
Bleeding in Liver Transplantation |
Other: plasma |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Plasma Transfusion in Liver Transplantation : a Randomized, Double Blind, Multicenter Trial of Methylene Blue, Solvent/Detergent and Quarantined Plasma. |
Estimated Enrollment: | 300 |
Study Start Date: | June 2005 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Quarantined FFP: Active Comparator
Quarantined FFP
|
Other: plasma
transfusion of more than 15 mL/Kg of plasma
|
Methylene blue FFP: Active Comparator
Methylene blue FFP
|
Other: plasma
transfusion of more than 15 mL/Kg of plasma
|
Solvent detergent FFP: Active Comparator
Solvent detergent FFP
|
Other: plasma
transfusion of more than 15 mL/Kg of plasma
|
Three types of plasma are transfused in bleeding patients undergoing liver transplantation:
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Françoise Courtois, MD | 33 1 44 49 66 07 | francoise.courtois@efs.sante.fr |
Contact: Anne Chabanel, ScD | 33 1 44 49 66 14 | anne.chabanel@efs.sante.fr |
France | |
EFS | Recruiting |
Paris, France, 75015 | |
Contact: Françoise Courtois, MD 33 1 44 49 66 07 francoise.courtois@efs.sante.fr | |
Contact: Anne Chabanel, ScD 33 1 44 49 66 14 anne.chabanel@efs.sante.fr | |
Principal Investigator: Françoise Courtois, MD |
Principal Investigator: | Yves Ozier, MD, PhD | Hôpital Cochin, Paris, France |
Principal Investigator: | Emmanuel Samain, MD, PhD | hôpital Jean Minjoz, Besançon, France |
Principal Investigator: | Marie - Christine Gillon, MD | Hôpital Paul Brousse, Villejuif, France |
Principal Investigator: | Loïc Villalon, MD | Hôpital Pontchaillou |
Responsible Party: | Etablissement Français du Sang ( President of EFS ) |
Study ID Numbers: | EFS plasma trial |
Study First Received: | October 6, 2005 |
Last Updated: | February 9, 2009 |
ClinicalTrials.gov Identifier: | NCT00235183 History of Changes |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
plasma bleeding liver transplantation |
Hemorrhage Methylene Blue |